EXPRESSION OF CONCERN: Antitumor Effects of a Novel Sulfur-Containing Hydroxamate Histone Deacetylase Inhibitor H40

IF 4.7 2区 医学 Q1 ONCOLOGY International Journal of Cancer Pub Date : 2025-02-12 DOI:10.1002/ijc.35373
{"title":"EXPRESSION OF CONCERN: Antitumor Effects of a Novel Sulfur-Containing Hydroxamate Histone Deacetylase Inhibitor H40","authors":"","doi":"10.1002/ijc.35373","DOIUrl":null,"url":null,"abstract":"<p><b>EXPRESSION OF CONCERN</b>: <span>J. Long</span>, <span>J. Zhao</span>, <span>Z. Yan</span>, <span>Z. Liu</span>, and <span>N. Wang</span>, “ <span>Antitumor Effects of a Novel Sulfur-Containing Hydroxamate Histone Deacetylase Inhibitor H40</span>,” <i>International Journal of Cancer</i> <span>124</span>, no. <span>5</span> (<span>2009</span>): <span>1235</span>–<span>1244</span>, https://doi.org/10.1002/ijc.24074.</p><p>This Expression of Concern is for the above article, published online on 22 October 2008 in Wiley Online Library (wileyonlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Christoph Plass; the Union for International Cancer Control (UICC); and Wiley Periodicals LLC. The Expression of Concern has been agreed due to concerns raised by third parties. Specifically, the article reports experiments in the unknown/unverifiable cell line BGC-803. Furthermore, the following cell lines used in the study have been reported as problematic: KB [<span>[1]-[4]</span>], BEL-7402 [<span>[5]</span>], and Hep-G2 [<span>[6]</span>]. A clarification addressing these concerns could not be obtained from the authors. As the detected issues do not undermine the overall conclusions of the article, the journal has decided to issue an Expression of Concern to inform and alert the readers.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"156 9","pages":"E14"},"PeriodicalIF":4.7000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.35373","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35373","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

EXPRESSION OF CONCERN: J. Long, J. Zhao, Z. Yan, Z. Liu, and N. Wang, “ Antitumor Effects of a Novel Sulfur-Containing Hydroxamate Histone Deacetylase Inhibitor H40,” International Journal of Cancer 124, no. 5 (2009): 12351244, https://doi.org/10.1002/ijc.24074.

This Expression of Concern is for the above article, published online on 22 October 2008 in Wiley Online Library (wileyonlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Christoph Plass; the Union for International Cancer Control (UICC); and Wiley Periodicals LLC. The Expression of Concern has been agreed due to concerns raised by third parties. Specifically, the article reports experiments in the unknown/unverifiable cell line BGC-803. Furthermore, the following cell lines used in the study have been reported as problematic: KB [[1]-[4]], BEL-7402 [[5]], and Hep-G2 [[6]]. A clarification addressing these concerns could not be obtained from the authors. As the detected issues do not undermine the overall conclusions of the article, the journal has decided to issue an Expression of Concern to inform and alert the readers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
关注表达:一种新型含硫羟酸组蛋白去乙酰化酶抑制剂H40的抗肿瘤作用。
关注表达:龙杰,赵杰,刘振华,王宁,“一种新型含硫羟酸组蛋白去乙酰化酶抑制剂H40的抗肿瘤作用”,《国际癌症杂志》,第24期。5 (2009): 1235-1244, https://doi.org/10.1002/ijc.24074.This对上述文章表示关注,该文章于2008年10月22日在线发表在Wiley在线图书馆(wileyonlinelibrary.com)上,并经该杂志总编辑Christoph Plass;国际癌症控制联盟;和Wiley期刊有限责任公司。由于第三方提出的担忧,已同意关注表达。具体来说,文章报道了未知/无法验证的细胞系BGC-803的实验。此外,研究中使用的以下细胞系被报道存在问题:KB [[1]-[4]], BEL-7402[[5]]和Hep-G2[[6]]。无法从作者那里得到关于这些问题的澄清。由于检测到的问题不会破坏文章的总体结论,该杂志决定发布关注表达,以通知和提醒读者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
期刊最新文献
Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain. Efficacy and safety of 5-aminolevulinic acid-based photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HPV infections. Associations of diabetes status, duration, and onset age with the risk of lung cancer: Results from the China Kadoorie Biobank study. Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study. Quality-adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1